secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-12-29T23:59:59+00:00
Accession:  0001493152-23-046578
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences special meeting canceled again due to lack of quorum; no vote on matters
--------------------------------------------------------------------------------

- Special meeting of stockholders scheduled for December 29, 2023 was not held due to lack of quorum.
- No matters were submitted to a vote; company had sought approval for matters related to October 23 Securities Purchase Agreement.
- Company must call a meeting every four months until stockholder approval is obtained or notes issued under Agreement are no longer outstanding.
- This is the second postponement; the meeting was originally set for December 20, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223046578/0001493152-23-046578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223046578/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-046578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer